Testosterone levels are declining faster than ever, affecting energy, mental clarity, heart health, and overall vitality. In this podcast Shalin Shah, CEO of Marius Pharmaceuticals explains the real causes behind low testosterone and introduces Kyzatrex—the first FDA-approved oral testosterone therapy designed to be safer, more accessible, and more effective than traditional methods.
Key Topics:
- Why testosterone levels are declining across generations
- The hidden symptoms and health risks of low testosterone
- Why free testosterone and SHBG matter more than total T
- Shalin Shah’s journey and the birth of Kyzatrex
- Comparison of old vs. new TRT delivery methods
- How Kyzatrex improves absorption, safety, and patient outcomes
- The importance of proper lab testing and monitoring
- Switching safely from injections or gels
- Future possibilities of hormone therapy for women
Key Takeaways:
- Low testosterone is a metabolic issue, not just a sexual one—affecting fatigue, mood, inflammation, heart, and brain health
- Many men suffer from low free testosterone even when total levels appear normal
- SHBG levels can block usable testosterone—testing for free T is crucial
- Kyzatrex offers a safe, liver-friendly oral alternative to injections and gels, with fewer side effects and better long-term outcomes
- Proper dosing, timing, and food intake are key to success with Kyzatrex
- Most users maintain fertility and avoid the blood thickening seen with older TRT forms
- Hormone therapy is evolving—and the stigma around it needs to go
As always, thanks for tuning in!
*****Click here to subscribe to our YouTube channel: / @drjonesnmdtv
Connect with Dr. Jones on Instagram: / doctorjones_doctorjones
*****Connect with Enovative Wellness Center on Facebook:/ gregjonesnmd
